Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

An exploratory investigation of brain collateral circulation plasticity after cerebral ischemia in two experimental C57BL/6 mouse models.

Foddis M, Winek K, Bentele K, Mueller S, Blumenau S, Reichhart N N, Crespo-Garcia S, Harnett D, Ivanov A, Meisel A, Joussen A, Strauss O, Beule D, Dirnagl U, Sassi C.

J Cereb Blood Flow Metab. 2019 Feb 7:271678X19827251. doi: 10.1177/0271678X19827251. [Epub ahead of print]

PMID:
31549895
2.

Re-thinking the Etiological Framework of Neurodegeneration.

Castillo X, Castro-Obregón S, Gutiérrez-Becker B, Gutiérrez-Ospina G, Karalis N, Khalil AA, Lopez-Noguerola JS, Rodríguez LL, Martínez-Martínez E, Perez-Cruz C, Pérez-Velázquez J, Piña AL, Rubio K, García HPS, Syeda T, Vanoye-Carlo A, Villringer A, Winek K, Zille M.

Front Neurosci. 2019 Jul 24;13:728. doi: 10.3389/fnins.2019.00728. eCollection 2019. Review.

3.

Exploratory Investigation of Intestinal Function and Bacterial Translocation After Focal Cerebral Ischemia in the Mouse.

Oyama N, Winek K, Bäcker-Koduah P, Zhang T, Dames C, Werich M, Kershaw O, Meisel C, Meisel A, Dirnagl U.

Front Neurol. 2018 Nov 19;9:937. doi: 10.3389/fneur.2018.00937. eCollection 2018.

4.

Immunomodulatory treatment with systemic GM-CSF augments pulmonary immune responses and improves neurological outcome after experimental stroke.

Dames C, Winek K, Beckers Y, Engel O, Meisel A, Meisel C.

J Neuroimmunol. 2018 Aug 15;321:144-149. doi: 10.1016/j.jneuroim.2018.03.005. Epub 2018 Mar 9.

5.

The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke.

Winek K, Dirnagl U, Meisel A.

Neurotherapeutics. 2016 Oct;13(4):762-774. doi: 10.1007/s13311-016-0475-x. Review.

6.

Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine Stroke.

Winek K, Engel O, Koduah P, Heimesaat MM, Fischer A, Bereswill S, Dames C, Kershaw O, Gruber AD, Curato C, Oyama N, Meisel C, Meisel A, Dirnagl U.

Stroke. 2016 May;47(5):1354-63. doi: 10.1161/STROKEAHA.115.011800. Epub 2016 Apr 7.

7.

Gut microbiota impact on stroke outcome: Fad or fact?

Winek K, Meisel A, Dirnagl U.

J Cereb Blood Flow Metab. 2016 May;36(5):891-8. doi: 10.1177/0271678X16636890. Epub 2016 Mar 4. Review.

8.

Cholinergic Pathway Suppresses Pulmonary Innate Immunity Facilitating Pneumonia After Stroke.

Engel O, Akyüz L, da Costa Goncalves AC, Winek K, Dames C, Thielke M, Herold S, Böttcher C, Priller J, Volk HD, Dirnagl U, Meisel C, Meisel A.

Stroke. 2015 Nov;46(11):3232-40. doi: 10.1161/STROKEAHA.115.008989. Epub 2015 Oct 8.

PMID:
26451017
9.

Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Römer C, Engel O, Winek K, Hochmeister S, Zhang T, Royl G, Klehmet J, Dirnagl U, Meisel C, Meisel A.

J Neurosci. 2015 May 20;35(20):7777-94. doi: 10.1523/JNEUROSCI.1532-14.2015.

10.

[Enterobacter cloacae--antimicrobial susceptibility of strains isolated from hospitalized patients in 2004-2005].

Młynarczyk A, Winek K, Wolska M, Caban A, Jabłońska M, Romul M, Wanyura A, Sawicka-Grzelak A, Młynarczyk G.

Med Dosw Mikrobiol. 2009;61(3):221-6. Polish.

PMID:
20120924
11.

[Assessment of the susceptibility of the gram-negative rods isolated from hospitalized patients to cefoperazone/sulbactam].

Młynarczyk G, Młynarczyk A, Wysocka PC, Scibisz A, Kostyra K, Sańczyk E, Jezewska G, Sliwa R, Winek K, Wolska M, Pastuszak A, Serafin I, Łuczak M.

Med Dosw Mikrobiol. 2008;60(1):51-8. Polish.

PMID:
18634344

Supplemental Content

Support Center